Advancing regenerative medicine
At Stemmatters, we are committed to driving innovation in regenerative medicine. We provide agile and flexible support to our customers to address their CMC needs and achieve successful clinical translation. We have competences and know-how in process development and aseptic manufacturing for different product types and formats.
Our solutions for your advanced therapy
Stemmatters is a fully integrated CDMO operating in human cell and tissue products, advanced cell therapies, and blood-derived biologicals.
Contract development
Stemmatters supports the development, optimisation, and translation of processes into cGMP-compliant drug products.
Contract manufacturing
Stemmatters can ensure all manufacturing steps from material reception to the final product’s fill & finish, batch release, storage, and retrieval.
Analytical services
Stemmatters provides comprehensive analytical support to ensure product quality, safety, and regulatory compliance.
Formulation development
Stemmatters' advanced biomaterial enables the development of combination products tailored to address multiple indications.
Why choose Stemmatters?
At Stemmatters, we are driven by a commitment to excellence, innovation, and collaboration. Here’s why we are the trusted partner for bringing your advanced therapies projects to life:
Looking for a partner in advanced therapies?
Let's discuss how we can support your project.
Latest news & Upcoming events
17 de Dezembro, 2024
Collaboration with Accelerated Biosciences
Accelerated Biosciences and Stemmatters Collaborate to Offer iPSC Derived from Human Trophoblast Stem Cells December 16, 2024 – Philadelphia, Pennsylvania and Guimarães, Portugal – Accelerated Biosciences […]
22 de Junho, 2023
Stemmatters is part of CAR T-REX International Consortium
CAR T-REX Consortium announces prestigious €2.7M Pathfinder Open Grant awarded by the European Innovation Council (EIC) to develop novel, scalable CAR T cell therapies with increased […]
12 de Maio, 2023
Collaboration with Pluristyx
Pluristyx and Stemmatters Announce Partnership to Develop and Manufacture iPSC-derived MSC Banks May 12, 2023 – Seattle, Washington and Guimarães, Portugal – Pluristyx and Stemmatters are […]
14 de Novembro, 2022
DCMatters – Projeto em co-promoção (SI I&DT) PT2020
Mortalidade por cancro tem crescido em Portugal 2,1 milhões de euros para estudar vacina contra tumores avançados Equipa portuguesa vai explorar associação de vacinas de células […]
26 de Outubro, 2022
Collaboration with MicrofluidX
MicrofluidX and Stemmatters partner on advancing automated 2D expansion of mesenchymal stem cells (MSCs) for cell therapy Stemmatters, a Portuguese CDMO with expertise in the manufacturing […]
15 de Junho, 2022
Stemmatters is part of PAT4CGT International Consortium
PAT4CGT Consortium Announces Prestigious €4.7M Pathfinder Grant Awarded by European Innovation Council for the Development of Modular Cell & Gene Therapy Manufacturing Platform PAT4CGT project will […]
24 de Abril, 2022
Collaboration with Limula and CEIDOS – Eurostars Grant
Swiss Start-ups Limula and Ceidos Receive Highly Competitive Eurostars Grant of over EUR 1 million to Partner with Portuguese CDMO Stemmatters and Augment Modular Cell Therapy […]
Have questions or want to connect with us?
Get in touch to learn more about our work and how we can collaborate.